Category: Latest News
-

Omeros Shares Jump After Finalizing $340 Million Novo Nordisk Deal
Omeros Corporation (NASDAQ:OMER) surged 12% on Monday after the company confirmed it has officially completed its asset purchase and license agreement with Novo Nordisk for zaltenibart, its clinical-stage MASP-3 inhibitor. The agreement, first unveiled on October 15, delivers an upfront cash payment of $240 million, which Omeros has already received. In total, the company could…
-

Laser Photonics Shares Slide After Nasdaq Flags Filing Delay
Laser Photonics Corp. (NASDAQ:LASE) saw its stock drop 8.3% in premarket trading on Monday after revealing it had received a non-compliance notice from Nasdaq tied to a delayed quarterly filing. The company said Nasdaq informed it on November 20, 2025, that it was out of compliance with listing standards because it had not submitted its…
-

Marvell Shares Gain as Microsoft Expands Azure Security Partnership Across Europe
Marvell Technology (NASDAQ:MRVL) traded 1.6% higher on Monday morning, outperforming the broader market after the chipmaker revealed an expanded security partnership with Microsoft (NASDAQ:MSFT) focused on strengthening cloud protections in Europe. The company said Microsoft is broadening its adoption of Marvell’s LiquidSecurity hardware security modules (HSMs), enabling Azure to offer additional cloud-based security services to…
-

Kala Bio Shares Jump After $6 Million Funding Deal With Investor David Lazar
KALA BIO, Inc. (NASDAQ:KALA) soared 28.3% in premarket trading on Monday after revealing that it has entered into a $6 million securities purchase agreement with private investor David E. Lazar. The company said it has already received $1.8 million from the first tranche of the two-part investment. As part of the deal, Lazar has taken…
-

Wolfspeed Shares Jump After Securing $698.6 Million IRS Refund
Wolfspeed Inc. (NYSE:WOLF) saw its stock climb 10.4% in premarket trading on Monday after announcing it has received $698.6 million in cash tax refunds from the Internal Revenue Service. The refund was issued under the Advanced Manufacturing Investment Credit in Section 48D of the U.S. tax code and accounts for a sizable portion of the…
-

Intercont (Cayman) Shares Skyrocket After Announcing Major Low-Carbon Shipping Partnership
Intercont (Cayman) Limited (NASDAQ:NCT) surged 47% in premarket trading on Monday after the company unveiled a new strategic partnership between its Singapore subsidiary, Openwindow, and CINCO INTERNATIONAL HONGKONG LIMITED. The collaboration is expected to deliver roughly $118.25 million in cumulative contract revenue and an estimated $88.96 million in cumulative net profit. The agreement focuses on…
-

ProMIS Neurosciences Shares Advance After New Data Supports Alzheimer’s Trial Strategy
ProMIS Neurosciences Inc. (NASDAQ:PMN) rose 6% on Monday after new research findings bolstered confidence in the company’s biomarker-focused approach to Alzheimer’s disease drug development. The company said a peer-reviewed paper published in Alzheimer’s & Dementia: Translational Research & Clinical Interventions found that plasma phosphorylated tau (pTau) biomarkers may serve as reliable early indicators of clinical…
-

FuelCell Energy Shares Decline After Company Secures $25 Million in EXIM Financing
FuelCell Energy Inc. (NASDAQ:FCEL) slid 4.3% on Monday following news that the company has finalized a new debt financing agreement with the Export-Import Bank of the United States (EXIM). The deal will provide roughly $25 million in gross proceeds before fees and reserves, giving the company additional capital to support its international growth plans, particularly…
-

IDEAYA Biosciences Shares Climb After FDA Clears Bispecific ADC Candidate
IDEAYA Biosciences Inc. (NASDAQ:IDYA) advanced 5.1% in premarket trading on Monday after revealing that the FDA has cleared its investigational new drug (IND) application for IDE034, a potential first-in-class bispecific B7H3/PTK7 TOP1 antibody-drug conjugate. The oncology-focused precision medicine company expects to launch a Phase 1 clinical trial in the first quarter of 2026. The initial…
-

Five Market Themes to Watch in the Week Ahead
A heavy slate of U.S. economic data will dominate attention this week as investors look to assess the health of the American economy before the Federal Reserve’s next rate decision. Expectations for a rate cut at next week’s meeting have been rising, but the upcoming indicators could offer a new—though delayed—window into inflation trends and…